Zebra introduces smart, non-invasive way for hospitals to track, provide real-time feedback on heart patients


Zebra Technologies Corporation (NASDAQ: ZBRA), a provider in solutions and services that provide real-time visibility into organizations’ assets, people and transactions, and Leiden University Medical Center (LUMC) in Leiden, the Netherlands announced the first commercial deployment of the Time Tracking Solution for Acute Myocardial Infarction (AMI) patients.

The technology will be shared for the first time during the European Society for Cardiology Congress in London.

According to the American Heart Association, heart disease is the No. 1 cause of death globally, leading to 17.3 million fatalities annually, and that number is expected to rise to more than 23.6 million by 2030. Acute myocardial infarction (AMI) occurs when blood flow is blocked in the coronary artery. As a result, part of the heart muscle is short on oxygen (ischemia) and damaged.


LUMC’s Cardiology Department set up the Door-To-Balloon (DTB) Task Force focused on ischemic time in heart infarction patients. DTB is the crucial period of time from when the patient enters the hospital to when the blockage is removed to restore blood flow by inflating a balloon during primary percutaneous coronary intervention (PCI). In order to reduce DTB time, real-time, accurate time tracking, evaluation and feedback is essential.

needle time


Zebra Technologies worked with LUMC to develop a solution powered by Zatar, Zebra’s Internet of Things (IoT) platform to enable hospitals to track patients and provide real-time feedback on DTB time. The real-time data provided allows all members of the caregiving team including cardiologists, ED physicians, nurses, EMS staff, technicians and administrators to focus on the reduction of DTB time.


  • LUMC completed a 6-month, 100-patient pilot review of the Time Tracking Solution and the solution has now moved into commercialization phase for all AMI patients.
  • The solution provides automatic time recording and real-time visibility into the time consumed on the AMI patients in treatment.
  • Hospitals can start using the solution very quickly as it installs in days without IT support and does not require significant training of staff.
  • The solution can be used in other time-critical emergency care, including Door-To-Needle (DTN) for tracking the time in response to acute ischemic stroke.
  • The solution is powered by Zebra’s Internet of Things (IoT) platform Zatar, Bluetooth Smart wristbands and digital display devices installed in-route from door to catherization lab in the hospital.


Prof. Dr. M.J. Schalij PhD MD, head of Cardiology, Leiden University Medical Center
“Zebra’s Time Tracking Solution for AMI patients allows us to track and evaluate door-to-balloon time in myocardial infarction patients. The system provides reliable, real-time feedback and helps us optimize the logistics chain in acute myocardial infarction care.”

Phil Gerskovich, senior vice president, New Growth Platforms, Zebra Technologies
“Our Time Tracking Solution for AMI patients is focused on helping hospitals focus on providing greater attention and care to patients in urgent, time-sensitive use cases. We are excited about completing the Leiden pilot and moving to production to benefit even more patients.”

Recent Articles

Specsavers selects Accenture to transform technology capabilities using the cloud

Posted on: June 21, 2021

Specsavers has selected Accenture to help improve and modernise its technology capabilities. This will drive efficiencies across its business and enhance the service experience for its customers, store partners, and colleagues.

Read more

Silex Insight’s TRNG selected for MiG-V from HENSOLDT Cyber

Posted on: June 18, 2021

Silex Insight, a provider of embedded security IP cores, has entered into an agreement with HENSOLDT Cyber, a developer of secure embedded systems for the IT market, to use Silex Insight’s True Random Number Generator (TRNG) as part of the highly secure RISC-V processor “Made in Germany”.

Read more